← All trials
NCT04549597
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 6, 2020
- Primary completion
- Jun 28, 2021
- Completion date
- Aug 5, 2021
- First posted
- Sep 16, 2020
- Last posted
- Sep 16, 2020
- Enrollment
- 330
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ArdelyxLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.